Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study
- PMID: 25925351
- PMCID: PMC4531875
- DOI: 10.1007/s10815-015-0488-0
Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study
Abstract
Purpose: Polycystic ovarian syndrome (PCOS) is a common cause of female infertility. Factors other than anovulation, such as low embryo quality have been suggested to contribute to the infertility in these women. This 2-year retrospective study used timelapse technology to investigate the PCOS-influence on timing of development in the pre-implantation embryo (primary endpoint). The secondary outcome measure was live birth rates after elective single-embryo transfer.
Methods: In total, 313 embryos from 43 PCOS women, and 1075 embryos from 174 non-PCOS women undergoing assisted reproduction were included. All embryos were monitored until day 6. Differences in embryo kinetics were tested in a covariance regression model to account for potential confounding variables: female age, BMI, fertilization method and male infertility.
Results: Time to initiate compaction and reach the morula stage as well as the duration of the 4th cleavage division was significantly shorter in PCOS embryos compared with non-PCOS embryos. No other kinetic differences were found at any time-points annotated. The proportion of multi-nucleated cells at the 2-cell stage was significantly higher in PCOS embryos compared with non-PCOS embryos. The live birth rates were comparable between the two groups.
Conclusion: The findings suggest that the causative factor for subfertility in PCOS is not related to timing of development in the pre-implantation embryo.
Trial registration: ClinicalTrials.gov NCT01953146.
Similar articles
-
In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts.Hum Reprod. 2015 Aug;30(8):1842-9. doi: 10.1093/humrep/dev125. Epub 2015 Jun 3. Hum Reprod. 2015. PMID: 26040479
-
Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation.Fertil Steril. 2017 Mar;107(3):606-612.e3. doi: 10.1016/j.fertnstert.2016.12.026. Epub 2017 Jan 27. Fertil Steril. 2017. PMID: 28139236
-
Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.Fertil Steril. 2008 Dec;90(6):2304-9. doi: 10.1016/j.fertnstert.2007.10.077. Epub 2008 Jan 14. Fertil Steril. 2008. PMID: 18191852
-
[Quality of oocytes and embryos from women with polycystic ovaries syndrome: State of the art].Gynecol Obstet Fertil Senol. 2017 Jul-Aug;45(7-8):429-438. doi: 10.1016/j.gofs.2017.06.015. Epub 2017 Jul 27. Gynecol Obstet Fertil Senol. 2017. PMID: 28757106 Review. French.
-
[Impact of polycystic ovary syndrome on oocyte and embryo quality].Gynecol Obstet Fertil. 2013 Jan;41(1):27-30. doi: 10.1016/j.gyobfe.2012.11.003. Epub 2012 Dec 31. Gynecol Obstet Fertil. 2013. PMID: 23286960 Review. French.
Cited by
-
Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?Eur J Obstet Gynecol Reprod Biol X. 2019 May 17;3:100045. doi: 10.1016/j.eurox.2019.100045. eCollection 2019 Jul. Eur J Obstet Gynecol Reprod Biol X. 2019. PMID: 31403129 Free PMC article.
-
Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.Steroids. 2022 Apr;180:108989. doi: 10.1016/j.steroids.2022.108989. Epub 2022 Feb 18. Steroids. 2022. PMID: 35189133 Free PMC article. Review.
-
Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.Ann Med Surg (Lond). 2022 Jun 25;79:104096. doi: 10.1016/j.amsu.2022.104096. eCollection 2022 Jul. Ann Med Surg (Lond). 2022. PMID: 35860057 Free PMC article.
-
Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls.F S Rep. 2020 Sep 2;1(2):125-132. doi: 10.1016/j.xfre.2020.05.006. eCollection 2020 Sep. F S Rep. 2020. PMID: 34223228 Free PMC article.
-
Which transfer day results in the highest live birth rate for PCOS patients undergoing in vitro fertilization?BMC Pregnancy Childbirth. 2023 Dec 16;23(1):865. doi: 10.1186/s12884-023-06173-5. BMC Pregnancy Childbirth. 2023. PMID: 38104082 Free PMC article.
References
-
- Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. - PubMed
-
- Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod. 1990;5:816–818. - PubMed
-
- Urman B, Fluker MR, Yuen BH, Fleige-Zahradka BG, Zouves CG, Moon YS. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril. 1992;57:1269–1273. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical